Alcidion Group Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Alcidion Group heeft een totaal eigen vermogen van A$86.9M en een totale schuld van A$0.0, wat de schuld-eigenvermogensverhouding op 0% brengt. De totale activa en totale passiva bedragen respectievelijk A$114.5M en A$27.5M.

Belangrijke informatie

Verhouding schuld/eigen vermogen

AU$0

Schuld

Rente dekkingsratio	n/a
Contant	AU$11.80m
Aandelen	AU$86.94m
Totaal verplichtingen	AU$27.52m
Totaal activa	AU$114.46m

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( A$18.5M ) van ALC } dekken niet de korte termijn passiva ( A$19.2M ).

Langlopende schulden: De kortetermijnactiva ALC ( A$18.5M ) overtreffen de langetermijnschulden ( A$8.3M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: ALC is schuldenvrij.

Schuld verminderen: ALC had 5 jaar geleden geen schulden.

Balans

Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: ALC heeft op basis van de huidige vrije kasstroom voldoende kasstroom voor meer dan een jaar.

Voorspelling contante baan: Er zijn onvoldoende gegevens om te bepalen of ALC voldoende cash runway heeft als de vrije kasstroom blijft groeien of krimpen op basis van historische percentages.

Alcidion Group Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

Alcidion Group Limited Announces Change of Company Secretary

Insufficient new directors

Alcidion Group Limited, Annual General Meeting, Oct 23, 2024

Full year 2024 earnings released: AU$0.006 loss per share (vs AU$0.003 loss in FY 2023)

Alcidion Group Limited Announces Board and Committee Changes

Alcidion Group Limited to Report Fiscal Year 2024 Results on Aug 29, 2024

Alcidion Group Limited to Report Q4, 2024 Results on Jul 30, 2024

Forecast to breakeven in 2025

Alcidion Group Limited Provides Revenue Guidance for the Second Half of 2024

Alcidion Group Limited to Report Q3, 2024 Results on Apr 18, 2024

New minor risk - Profitability

Alcidion Group Limited to Report First Half, 2024 Results on Feb 28, 2024

Alcidion Group Limited to Report Q2, 2024 Results on Jan 31, 2024

Alcidion Group Limited has completed a Follow-on Equity Offering in the amount of AUD 5.025 million.

New minor risk - Shareholder dilution

Alcidion Group Limited has filed a Follow-on Equity Offering in the amount of AUD 1 million.

Alcidion Group Limited to Report Q1, 2024 Results on Oct 31, 2023

Alcidion Group Limited, Annual General Meeting, Nov 20, 2023

Now 22% undervalued

Full year 2023 earnings released: AU$0.003 loss per share (vs AU$0.004 loss in FY 2022)

Alcidion Group Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

Alcidion Group Limited to Report Q4, 2023 Results on Jul 27, 2023

Now 21% undervalued after recent price drop

Independent Non-Executive Director recently bought AU$55k worth of stock

Forecast breakeven date moved forward to 2023

Forecast breakeven date pushed back to 2024

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.006 loss in 1H 2022)

Alcidion Group Limited to Report First Half, 2023 Results on Feb 24, 2023

Alcidion Group Limited to Report First Half, 2023 Results on Jan 30, 2023

Alcidion Group Limited Announces Malcolm Pradhan Stepping Down as Executive Director and Chief Medical Officer

Alcidion Group Limited to Report Q1, 2023 Results on Oct 31, 2022

Full year 2022 earnings released: AU$0.004 loss per share (vs AU$0.002 loss in FY 2021)

Alcidion Group Limited, Annual General Meeting, Oct 25, 2022

Alcidion Group Limited to Report Fiscal Year 2022 Results on Aug 30, 2022

Alcidion Group Limited to Report Q4, 2022 Results on Jul 27, 2022

Forecast breakeven date pushed back to 2023

Alcidion Group Limited to Report Q3, 2022 Results on Apr 27, 2022

Forecast breakeven date pushed back to 2023

First half 2022 earnings: EPS in line with analyst expectations despite revenue beat

Alcidion Group Limited to Report First Half, 2022 Results on Feb 23, 2022

Alcidion Group Limited (ASX:ALC) completed the acquisition of Silverlink Software Limited.

Alcidion Group Limited (ASX:ALC) agreed to acquire Silverlink Software Limited for £33 million.

Forecast to breakeven in 2022

Less than half of directors are independent

Full year 2021 earnings released: AU$0.002 loss per share (vs AU$0.003 loss in FY 2020)

Alcidion Group Limited Provides Earnings Guidance for the Fiscal 2022

Co-Founder & Non-Executive Director Raymond Blight has left the company

Insider recently bought AU$3.9m worth of stock

Alcidion Signs Contract with Te Manawa Taki DHBs for Electronic Medication Management

First half 2021 earnings released: AU$0.001 loss per share (vs AU$0.002 loss in 1H 2020)

New 90-day high: AU$0.26

Alcidion Group Limited to Report First Half, 2021 Results on Feb 25, 2021

New 90-day high: AU$0.21

Alcidion Group Limited to Report Q2, 2021 Results on Jan 27, 2021

Alcidion Group Limited Announces an Extension of its Contract with South Tees Hospitals NHS Foundation Trust

Alcidion Group Limited Announces Reseller Agreement with Nextgate Solutions, Inc

New 90-day high: AU$0.21

Alcidion Group Limited Signs $9.5 Million Deal with NHS Trust

Alcidion Group Limited to Report Q1, 2021 Results on Oct 27, 2020

Insider recently bought AU$195k worth of stock

Full year earnings released - AU$0.0033 loss per share

Alcidion Group Limited to Report Fiscal Year 2020 Results on Aug 27, 2020

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Analyse van de cashflow

Ontdek gezonde bedrijven